SCHEMBL19981776

SCHEMBL19981776

CC1(C)CB(c2ccc(F)c(N)c2)OC1(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.33
LIPG Q9Y5X9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21154235 0.78 LPL (0.49) LPLLIPG
SCHEMBL8081012 0.78 LPL (0.31) LPLLIPG
SCHEMBL1290153 0.77 LPL (0.51) LPLLIPG
SCHEMBL23153800 0.77
SCHEMBL25902940 0.76 CYP3A4 (0.34) LPLLIPG
SCHEMBL14700056 0.76
SCHEMBL23635134 0.75 PDGFRB (0.34)
SCHEMBL26834607 0.73 MAPT (0.32)
SCHEMBL1130911 0.73 HSPB1 (0.34) LPLLIPG
SCHEMBL19003095 0.72 CYP11B1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed